Detalhe da pesquisa
1.
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
N Engl J Med
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739079
2.
Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study.
J Card Fail
; 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215932
3.
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF.
J Card Fail
; 30(1): 26-35, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683911
4.
Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4.
J Card Fail
; 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38493832
5.
EstimATTR: A Simplified, Machine-Learning-Based Tool to Predict the Risk of Wild-Type Transthyretin Amyloid Cardiomyopathy.
J Card Fail
; 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38065306
6.
Correction of a pathogenic gene mutation in human embryos.
Nature
; 548(7668): 413-419, 2017 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28783728
7.
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
Eur Heart J
; 43(23): 2212-2220, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325102
8.
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial.
Eur Heart J
; 43(48): 5006-5016, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35675469
9.
Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy.
Cardiovasc Ultrasound
; 20(1): 23, 2022 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36117179
10.
Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial.
JAMA
; 328(3): 259-269, 2022 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852527
11.
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.
N Engl J Med
; 379(1): 22-31, 2018 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29972757
12.
Inferior vena cava dilation predicts global cardiac dysfunction in acute respiratory distress syndrome: A strain echocardiographic study.
Echocardiography
; 38(2): 238-248, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33428265
13.
Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy: A Clinical Trial.
Ann Intern Med
; 170(11): 741-748, 2019 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31035291
14.
Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Children with Cardiac Conditions Associated with Risk for Sudden Cardiac Death.
Pediatr Cardiol
; 41(7): 1484-1491, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32623612
15.
Ma et al. reply.
Nature
; 560(7717): E10-E23, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30089923
16.
Safety profile of ultrasound enhancing agents in echocardiography.
Echocardiography
; 36(6): 1041-1044, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31038768
17.
Right Ventricular Systolic Performance Determined by 2D Speckle-Tracking Echocardiography and Acute Kidney Injury After Cardiac Surgery.
J Cardiothorac Vasc Anesth
; 33(3): 725-731, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30316640
18.
Aficamten for Drug-Refractory Severe Obstructive Hypertrophic Cardiomyopathy in Patients Receiving Disopyramide: REDWOOD-HCM Cohort 3.
J Card Fail
; 29(11): 1576-1582, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37473912
19.
Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial.
J Inherit Metab Dis
; 40(6): 831-843, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28871440
20.
Hot hearts on bone scintigraphy are not all amyloidosis: hydroxychloroquine-induced restrictive cardiomyopathy.
Eur Heart J
; 41(25): 2414, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32077932